Bristol-Myers Squibb Company
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists

Abstract:

The present invention provides compounds of Formula (I): ##STR00001## or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.